Appeal 2007-4316 Application 09/911,268 superiority to the presence of the finely divided inorganic material F, which is absent from comparative example 1. According to Eckel 930, component F counteracts the deleterious effects of the organophosphate. (FF 16; Eckel 930 at 13:45–58.) Moreover, the present inventors attribute a flame resistance of V-1 to the presence of 9 w% IPP. (Specification at 3:14–16.) Thus, the flame resistance value for Comparative example 1 in Eckel 930 may support a conclusion that IPP is present at a significant level, i.e., at a level higher than 1 w%. We also recognize—as apparently did the Examiner (Answer at 6)—that Dr. Eckel did not say what the IPP content of the Eckel 930 D.1 compound was. This is a curious omission, since Dr. Eckel was the first-named inventor on the Eckel 930 patent and presumably knows or is in a position to determine the IPP content and the source of the D.1 compound. In view of these various facts that weigh for and against the level of IPP in the Eckel 930 reference, and the incomplete record, we decline to exercise our discretion under 37 C.F.R. § 41.50(b) to enter a new ground of rejection. Instead, we leave the development of these issues to the Examiner and Applicants in the first instance. D. Summary In view of the record and the foregoing considerations, it is: ORDERED that the rejection of claims 1–17 under 35 U.S.C. § 102(e), alternatively under 35 U.S.C. § 103(a) over Eckel 930 is REVERSED; FURTHER ORDERED that the rejection of claims 1–17 under 35 U.S.C. § 102(b) over Gaggar is REVERSED; and 11Page: Previous 1 2 3 4 5 6 7 8 9 10 11 12 Next
Last modified: September 9, 2013